Featuring the top biotech and pharmaceutical companies of Belgium.

The biotechnology industry is on the rise in BioBelgium. During the 1990s, Belgium saw an increase in the amount of biotech and pharmaceutical companies within the small country. According to Ernst & Young, Belgium has seen an increase in venture capital over the past year creating an environment suited for advanced development. BioBelgium is expected to continue expanding in this small but influential country.

Join the World Discussion Forum


Hotbed News
Galapagos Reports High Participation Rate In Long Term Extension Study With GLPG0634 In RA Patients Thursday, September 18, 2014
Cardio3 BioSciences Receives Approval For The Continuation Of Its Chart-1 Phase III Clinical Trial From The DSMB Tuesday, September 16, 2014
Illinois-Based Akorn, Inc. (AKN) Eyes $2 Billion UCB SA Unit In Potential Tax Inversion Deal Monday, September 15, 2014
TiGenix To Participate Or Present At Key Conferences In The Second Half Of 2014 Monday, September 15, 2014
Biocartis Launches Its Flagship Molecular Diagnostics Platform Idylla™ Friday, September 12, 2014
VolitionRX NuQ(R) Blood Test Detects 84% Of Colorectal Cancers; Including Both Early- And Later-Stage Cancers Thursday, September 11, 2014
Galapagos NV (GLPG.BR), GlaxoSmithKline (GSK) Abandon Joint Drug Project Due To Adverse Effects Wednesday, September 10, 2014
Janssen-Cilag International NV (JNJ) Supports The TeamBG Cycle Tour Raising Awareness Of Diabetes Wednesday, September 10, 2014
Polyester Clothes Stink After Exercise; Cotton, Not So Much, Ghent University Study Tuesday, September 09, 2014
Bayer AG (BAYZF), Boehringer Ingelheim Corporation, Perrigo Company (PRGO), And Sanofi (France) (SAN.PA) Linked To Omega Pharma NV (0OMEP.BR) Sale; Deal Could Cost More Than $5.3 Billion Tuesday, September 09, 2014
12345678910